🇺🇸 FDA
Patent

US 6169068

Pulmonary administration of soluble complement receptor-1 (sCR1) and its derivatives

expired A61KA61K38/00A61K9/0078

Quick answer

US patent 6169068 (Pulmonary administration of soluble complement receptor-1 (sCR1) and its derivatives) held by Regents of the University of Minnesota expires Mon Dec 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Regents of the University of Minnesota
Grant date
Tue Jan 02 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
31
CPC classes
A61K, A61K38/00, A61K9/0078, A61P, A61P11/00